night sweats tirzepatide Does Mounjaro cause sweats? What the evidence shows What causes night sweats and

Second, rapid weight loss even healthy, medically supervised weight loss puts stress on bone density

Planning for the ongoing investment in health and receiving support throughout the treatment journey is key

Journal of Investigative Dermatology , 126(8), 1869-1878

(If it doesnt start moving, press down harder on the pen.) You should hear two clicks during the injection

By 8-12 weeks, the majority of patients who initially experienced gastrointestinal symptoms find them minimal or absent

Primary candidates for GLP-1 therapy include: Patients with type 2 diabetes and inadequate glycemic control despite metformin therapy Individuals with type 2 diabetes and established atherosclerotic cardiovascular disease Patients with type 2 diabetes and multiple cardiovascular risk factors (hypertension, dyslipidemia, obesity) Adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities Patients with metabolic syndrome who have not achieved adequate risk factor control with lifestyle modification For patients with dyslipidemia, GLP-1 agents may be particularly valuable when combined with statin therapy in those who have not reached LDL-C goals or who have persistent hypertriglyceridemia despite statin treatment